

Cover Story
Guest Editorial
As the world faced the threat of a novel respiratory pathogen, SARS-CoV-2, in the first months of 2020, there was a great deal of uncertainty about its effect on people, especially those living with a diagnosis of cancer.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Otis Brawley looks back on a year of great science and greater challenges
- Elisa Rodriguez named first chief diversity and equity officer for faculty at Roswell Park
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Gregory Curt, Clinician and Drug Developer, Dies at 64
- Twitter star Vinay Prasad retires @VinayPrasadMD
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program














